Clal Insurance’s NVIDIA NVDA Stock Holding History

Clal Insurance’s Portfolio NVDA Stock Details NVDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,800	Closed	-$3.33M	–	236
2026 Q1	$3.33M	Buy	+4,800	New	+$881K	0.02%	98

Other funds holding NVDA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Clal Insurance's NVDA Position: Q2 2026 in Review

Clal Insurance increased its NVIDIA (NVDA) stake by 61% in Q2 2026, buying an estimated $122M and bringing the position to 1,575,211 shares worth $315M. The position accounts for 1.41% of the portfolio, ranked #12.

Clal Insurance first reported a position in NVDA in Q2 2019 and has held it in 29 quarters since. 5,101 funds tracked by Wall St. Rank hold NVDA as of Q2 2026.

Clal Insurance held 1,575,211 shares of NVIDIA worth $315M as of Q2 2026.
Clal Insurance bought 594,725 NVIDIA shares in Q2 2026, an estimated $122M.
NVIDIA made up 1.41% of Clal Insurance's portfolio in Q2 2026, its #12 holding.
Clal Insurance first reported a position in NVIDIA in Q2 2019 and has held it in 29 quarters since.
5,101 funds tracked by Wall St. Rank held NVIDIA as of Q2 2026.

Based on Clal Insurance's 13F filing for Q2 2026, filed 13 Aug 2026.